Benzyl Pharmaceuticals Private Limited
About Benzyl Pharmaceuticals Private Limited
Data last updated:
Benzyl Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 24 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2017PTC092527. Its GSTIN is 09AAHCB2088D1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Atul Kumar Sinha and Abhishek Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 18 Arunachalam Apartments Kabeer Marg Opp. Yojna Bhawan 5 Clay Square, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.3 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹4.37 Lakh (net margin 52.6%) and EBITDA of ₹4.37 Lakh (EBITDA margin 52.7%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Benzyl Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. 18 Arunachalam Apartments Kabeer Marg Opp. Yojna Bhawan 5 Clay Square, Lucknow, Uttar Pradesh, India – 226001
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Benzyl Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Benzyl Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Benzyl Pharmaceuticals Private Limited, buy the company report.
Financials of Benzyl Pharmaceuticals Private Limited
FY 2025 filings availableBenzyl Pharmaceuticals Private Limited reported revenue of ₹8.3 Lakh (up 32% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 32% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 24%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 52.7% | ||||
| Net Profit Margin | 52.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Benzyl Pharmaceuticals Private Limited, buy the company report.
Board of directors of Benzyl Pharmaceuticals Private Limited
Benzyl Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Kumar Sinha | Director | 24 Apr 2017 | 9 Years 6 Months | Current |
| Abhishek Kumar | Director | 24 Apr 2017 | 9 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Benzyl Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Benzyl Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Benzyl Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCB2088D1ZQ | Uttar Pradesh | Active | 02 Nov 2017 |
To see the full GST registrations and return filing status of Benzyl Pharmaceuticals Private Limited, buy the company report.
Recent activity
Benzyl Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Abhishek Kumar was appointed as Director on 24 Apr 2017.
Frequently asked questions
Benzyl Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 24 April 2017 (9+ years old) and is registered under CIN U51909UP2017PTC092527.
Benzyl Pharmaceuticals has 2 current directors:
- Atul Kumar Sinha - Director
- Abhishek Kumar - Director
The latest financial statements of Benzyl Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Benzyl Pharmaceuticals is 09AAHCB2088D1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Benzyl Pharmaceuticals is U51909UP2017PTC092527. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Benzyl Pharmaceuticals was incorporated on 24 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
Abhishek Kumar was appointed as Director on 24 Apr 2017. Atul Kumar Sinha was appointed as Director on 24 Apr 2017.
The registered office of Benzyl Pharmaceuticals is at Flat No. 18 Arunachalam Apartments Kabeer Marg Opp. Yojna Bhawan 5 Clay Square, Lucknow, Uttar Pradesh, India – 226001.
Benzyl Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Benzyl Pharmaceuticals is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
